Correlation Between Arcellx and Zentalis Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcellx and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Arcellx and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Zentalis Pharmaceuticals.

Diversification Opportunities for Arcellx and Zentalis Pharmaceuticals

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Arcellx and Zentalis is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Arcellx i.e., Arcellx and Zentalis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Arcellx and Zentalis Pharmaceuticals

Given the investment horizon of 90 days Arcellx is expected to generate 0.51 times more return on investment than Zentalis Pharmaceuticals. However, Arcellx is 1.95 times less risky than Zentalis Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.08 per unit of risk. If you would invest  6,648  in Arcellx on January 17, 2025 and sell it today you would lose (446.00) from holding Arcellx or give up 6.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Arcellx  vs.  Zentalis Pharmaceuticals Llc

 Performance 
       Timeline  
Arcellx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Arcellx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Zentalis Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zentalis Pharmaceuticals Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Arcellx and Zentalis Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcellx and Zentalis Pharmaceuticals

The main advantage of trading using opposite Arcellx and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.
The idea behind Arcellx and Zentalis Pharmaceuticals Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.